|
End-of-day quote
Egyptian Exchange
2026-08-12
|
5-day change | 1st Jan Change | ||
| 1.580 EGP | 0.00% |
|
+6.04% | +38.60% |
| May. 17 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| Feb. 19 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 901M 17.94M 15.54M 14.56M 13.28M 24.97M 1.71B 25.36M 171M 66.95M 857M 67.35M 65.89M 2.86B | P/E 2026 * |
26.3x | P/E 2027 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise Value | 821M 16.35M 14.17M 13.27M 12.11M 22.76M 1.56B 23.11M 156M 61.03M 781M 61.4M 60.06M 2.6B | EV / Sales 2026 * |
0.69x | EV / Sales 2027 * | 0.51x |
| Free-Float |
30.46% | Yield 2026 * |
1.9% | Yield 2027 * | 2.53% |
| 1 week | +6.04% | ||
| Current month | +6.04% | ||
| 1 month | +18.80% | ||
| 3 months | +24.41% | ||
| 6 months | +17.91% | ||
| Current year | +38.60% |
| 1 week | 1.48 |  | 1.74 |
| 1 month | 1.32 | | 1.74 |
| Current year | 1.02 | | 1.74 |
| 1 year | 0.81 | | 4.11 |
| 3 years | 0.81 | | 4.11 |
| 5 years | 0.81 | | 5.28 |
| 10 years | 0.81 | | 5.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Khaled Kamel
CEO | Chief Executive Officer | - | - |
Zeina Shahin
IRC | Investor Relations Contact | - | - |
Tamer Raouf
SAM | Sales & Marketing | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Ahmed El-Nayeb
CHM | Chairman | - | 2001-12-31 |
Tamir Saeed
BRD | Director/Board Member | - | 2020-12-31 |
Norbert Lurz
BRD | Director/Board Member | - | 2020-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +6.04% | -26.85% | -40.38% | 17.95M | |
| +0.43% | +4.31% | +90.84% | +130.99% | 1,083B | |
| +0.41% | +1.27% | +50.98% | +50.05% | 626B | |
| -0.53% | +1.04% | +25.23% | +63.46% | 442B | |
| -0.92% | +0.22% | +48.34% | +37.85% | 363B | |
| -1.32% | -0.21% | +29.07% | +36.81% | 295B | |
| -1.20% | -2.78% | +5.56% | +6.09% | 248B | |
| +0.45% | +2.05% | +46.04% | +58.54% | 224B | |
| -2.51% | +1.77% | -6.55% | -51.74% | 210B | |
| +0.07% | +3.12% | +13.21% | +69.84% | 168B | |
| Average | -0.51% | +2.04% | +27.58% | +36.15% | 365.91B | |
| Weighted average by Cap. | -0.26% | +2.19% | +49.22% | +65.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.19B 23.7M 20.53M 19.24M 17.54M 32.98M 2.26B 33.49M 226M 88.43M 1.13B 88.97M 87.03M 3.77B | 1.55B 30.9M 26.77M 25.09M 22.88M 43.02M 2.95B 43.68M 295M 115M 1.48B 116M 114M 4.92B |
| Net income | 206M 4.1M 3.55M 3.33M 3.04M 5.71M 391M 5.8M 39.16M 15.31M 196M 15.4M 15.07M 653M | 283M 5.64M 4.88M 4.57M 4.17M 7.84M 537M 7.96M 53.8M 21.03M 269M 21.16M 20.7M 897M |
| Net Debt | -79.7M -1.59M -1.37M -1.29M -1.18M -2.21M -151M -2.24M -15.15M -5.92M -75.79M -5.96M -5.83M -253M | -110M -2.19M -1.9M -1.78M -1.62M -3.05M -209M -3.1M -20.91M -8.17M -105M -8.22M -8.05M -349M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-12 | EGP 1.580 | 0.00% | 66,925,294 |
| 26-08-11 | EGP 1.580 | -3.07% | 201,347,038 |
| 26-08-10 | EGP 1.630 | +4.49% | 128,353,657 |
| 26-08-09 | EGP 1.560 | +5.41% | 181,316,412 |
| 26-08-06 | EGP 1.480 | -0.67% | 66,369,592 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.580EGP
Average target price
1.570EGP
Spread / Average Target
-0.63%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- MCRO Stock
Select your edition
All financial news and data tailored to specific country editions
